ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment

Welcome to another episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain continue their ToxCheck series, focusing on the management of side effects associated with treatments for pancreatic cancer.

Join us as we dive deep into the use of key drugs such as 5-FU, oxaliplatin, irinotecan, liposomal irinotecan, and the combination of gemcitabine and nab-paclitaxel. We are joined by esteemed guests Dr. Rachna Shroff from the University of Arizona and Dr. Midhun Malla from the University of Alabama, who share their insights and clinical pearls on managing the challenging side effects of these therapies.

Key topics discussed include:
•⁠  ⁠The utility of 5-FU bolus and leucovorin in treatment regimens
•⁠  ⁠Managing common side effects like diarrhea, mucositis, and neuropathy
•⁠  ⁠The importance of preemptive strategies in side effect management
•⁠  ⁠Insights on liposomal irinotecan and its tolerability
•⁠  ⁠The impact of gemcitabine and nab-paclitaxel on quality of life

Whether you're a healthcare professional or someone interested in oncology, this episode provides valuable information on optimizing treatment while maintaining patient quality of life.

YouTube: https://youtu.be/KByOGRpzFMQ

Follow us on social media:
•⁠  ⁠X/Twitter: https://twitter.com/oncbrothers
•⁠  ⁠Instagram: https://www.instagram.com/oncbrothers
•⁠  Website: https://oncbrothers.com/

Don't forget to check out our other ToxCheck episodes on antibody drug conjugates, CAR-T, and anti-EGFR drugs used in colorectal cancer.

Subscribe for more insights from the Oncology Brothers!